
The Cigna Group Ventures is the strategic venture capital arm of The Cigna Group (NYSE: CI), a leading global health service company. It partners with health care startups across areas including digital health, insights and analytics, and care delivery and enablement, providing capital and access to Cigna's resources. The fund invests in early- and growth-stage companies to drive health care transformation and innovation.
62% of their portfolio is in Healthcare. Average disclosed round size is $56.7M (across 38 rounds with reported amounts).
Portfolio
30
Fund Size
$450M
Top Stage
Series B
Last 12 Mo
0
Team
Tom Olenzak
Managing Director Cigna Ventures
Matthew Blum
Sr. Principal at Cigna Ventures
Nikolas Koenning
Principal at Cigna Ventures
Craig Cimini
Head of The Cigna Group Ventures
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Series C | $106M | Dec 2024 | |
| Series A | $9.5M | Feb 2024 | |
| Series C | $52M | Jun 2023 | |
| Growth | $23M | Jan 2023 | |
| OOctave Health Group Inc. | Series C | $52M | Jan 2023 |
| Growth | $44.5M | Oct 2022 | |
| Unknown | $130M | Aug 2022 | |
| HHelloalma Com | Series D | $130M | Aug 2022 |
| Series D | $130M | Aug 2022 | |
| Series A | $30M | Mar 2022 | |
| Series C | $106M | Jan 2022 | |
| ZZerigo Health | Series B | $43M | Oct 2021 |
| Series B | $83.5M | Aug 2021 | |
| CCleerly Coronary | Series B | $43M | Jun 2021 |
| OOctave Health Group Inc. | Series B | $20M | May 2021 |
| Series B | $20M | May 2021 | |
| Series B | $40M | Oct 2020 | |
| Series A | — | Oct 2020 | |
| Growth | $29.5M | Jan 2020 | |
| GGNS Healthcare | Series D | $23M | Jul 2019 |
| Series C | $73M | Jun 2019 | |
| Series D | $73M | Jun 2019 | |
| Series D | $73M | Jan 2019 | |
| Growth | $30M | Jan 2019 | |
| Bridge | $84M | Jan 2018 |
Top Co-Investors
Last updated: 7 October 2026